KLF4 and esophageal squamous cell carcinoma: As described by Chen et al. [48], KLF4 increased the sensitivity of Cisplatin by the induction of apoptosis and cell cycle arrest in the S-phase in esophageal squamous cell carcinoma (ESCC) cells.